News focused on: Lab Long; S Alice Long, PhD
Press Release
A Subset of Expanded Regulatory T Cells Is Linked With C-Peptide Preservation in Children With New Onset Type 1 Diabetes
Read More
External News
Science in Seattle: A first-in-human, open-label Phase 1b and a randomised, double-blind Phase 2a clinical trial in recent-onset type 1 diabetes with AG019 as monotherapy and in combination with teplizumab
Read the publication ➡
News
BRI Investigator Alice Long, PhD, Interviewed on the Immunology Podcast
Read More
Press Release
Benaroya Research Institute Receives $9 Million in Funding, With a Focus on Down Syndrome Research
Read More
External News
Publication of the Week: Deep Immune Phenotyping Reveals Similarities between Aging, Down Syndrome, and Autoimmunity
Read publication ➡
Press Release
Type 1 Diabetes Discovery Opens Door to Game-Changing Treatment Strategies
Read More
News
T Cell Exhaustion in New-Onset Type 1 Diabetes Treatment
Read More
News
BRI to Unravel Insulin Mystery in Type 1 Diabetes: $1.4 Million Grant from JDRF to Understand Critical Question
Read MorePress Release
